by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : July 2009
AusBioSTATES The purpose of this Fund is to seed new projects for partners that are unable to access these facilities at the low access fees under NCRIS for meritorious researchers and/or host university academics. The commercial rates for industry partners are higher and thus often act as a threshold for commercial entities to access these academic centres. The NSW government (Office of Science and Medical Research/Department of State and Regional Development) has joined forces with the host universities of these facilities to increase patronage by offering a dollar-for-dollar contribution to initial projects through the creation of this Fund. The idea is to assist NSW organisations first, but applications (and collaborations) with interstate and international industry partners are more than welcome. For more information, please contact Frits Moscou, Business Development Manager NCRIS NSW 5.1 on 02 9805 3176 or via email email@example.com What other stories are out there that we don’t know about? Since my last report, I have had a number of organisations and people contact me and we are engaging them into this important network called AusBiotech. Tell us what you are working on, how you are helping people. For further information contact: Ian Dixon - Chair Vic Branch AusBiotech on 03 9894 4555 or firstname.lastname@example.org Victoria Calling all unsung and little-known Victorian biotechs… When I was a three years old (in 1959) I had rheumatic fever. Antibiotics and three months in hospital saved my life and enabled me to lead a normal life without complications. In 2002 my daughter had appendicitis then peritonitis and then early-stage sepsis and could have died; but today has a vibrant life and works for a multi-national firm. Right now our loved family pet of nine years has terminal cancer and will die within days/weeks of inoperable tumour detected only four weeks ago. Every day people need new medical devices, diagnostics and therapeutics to improve their lives and make the world a better place. People and those close to us had or have problems that biotechnology has solved or will soon solve. The story of penicillin is a success story to be retold and retold. Professor Ian Frazer’s vaccine is a biotechnology success story in our own time. Cochlear implants have transformed the lives of those born without hearing. New tests alert us to the need for regime-change in our lives. Agbio promises the era of food for all. Guest speaker at the recent AusBiotech executive lunch, Stephen Nash, MD of Merriman Curhan Ford’s OTCQX Advisory Group, said Australian biotech companies still hold appeal for US investors. Pictured with AusBiotech CEO, Dr Anna Lavelle. Professor Michael Vitale welcomes a very special attendee at the executive lunch, Alba. Volume 19 • Number 2 • July 2009 Australasian BioTechnology 57